Betaxolol dosage and administration: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Betaxolol}} {{CMG}}; {{AE}} {{SS}} ==Dosage and Administration== The recommended dose is one to two drops of BETOPTIC Ophthalmic Solution in the affected eye(s) t...") |
(No difference)
|
Revision as of 21:03, 3 February 2014
Betaxolol |
---|
BETOPTIC® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
Clinical Studies |
How Supplied/Storage and Handling |
Clinical Trials on Betaxolol |
ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Dosage and Administration
The recommended dose is one to two drops of BETOPTIC Ophthalmic Solution in the affected eye(s) twice daily. In some patients, the intraocular pressure lowering responses to BETOPTIC Ophthalmic Solution may require a few weeks to stabilize. As with any new medication, careful monitoring of patients is advised.
If the intraocular pressure of the patient is not adequately controlled on this regimen, concomitant therapy with pilocarpine and other miotics, and/or epinephrine and/or carbonic anhydrase inhibitors can be instituted.[1]
References
- ↑ "BETOPTIC (BETAXOLOL HYDROCHLORIDE) SOLUTION/ DROPS [ALCON]". Retrieved 3 February 2014.